The FDA maintains a drug shortage database based on several key criteria: When manufacturers report anticipated disruptions or discontinuances in drug production When the FDA becomes aware of significant supply issues through market surveillance When healthcare providers or patients report consistent difficulty obtaining medications When a drug's demand significantly exceeds available supply On October 30, 2024, Novo Nordisk confirmed that all doses of Wegovy and Ozempic are now listed as available in the U.S., although the company cautioned people may still experience variability in filling their prescriptions
Key Points: Semaglutide is the active pharmaceutical ingredient in three brand-name medications: Wegovy, Ozempic, and Rybelsus.[1-3] For patients with obesity or who are overweight with at least one weight-related comorbidity, semaglutide may be prescribed for weight management.[1] For patients with type 2 diabetes (T2D), semaglutide is prescribed to improve glucose control.[2,3] To get a semaglutide prescription, you can visit your primary care physician in person or schedule an online appointment with a healthcare professional.[1-3] As obesity and T2D rates continue to rise, more people are seeking medication to help manage weight and related health conditions.[4,5] Growing in popularity as a medical weight loss treatment, semaglutide offers a newer option for individuals struggling with excess weight
DOI:10.4236/wjet.2018.63042
Giving the injections was quite easy and the kit came with everything needed
Copp J P, Desprez P Y, Krtolica A, et al
This rapid appetite suppression happens because semaglutide directly mimics glucagon-like peptide-1, a natural hormone that regulates hunger signals
